Related Experiment Video
Updated: May 14, 2026

05:28
Clinical Imaging of Microwave Mammography
Published on: November 14, 2025
Explainable Artificial Intelligence in Mammography: A Systematic Review of Methods, Evaluation Practices, and
Filippo Pesapane1, Anna Rotili1, Silvia Penco1
1Breast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Diagnostics (Basel, Switzerland)
|May 13, 2026
Summary
Explainable AI (XAI) in mammography shows visually plausible but inconsistently validated explanations. Further research needs robust validation and clinician-centered evaluation for clinical readiness.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Radiology
Background:
- Explainable artificial intelligence (XAI) is proposed to enhance trust in AI mammography systems.
- The clinical validity and readiness of current XAI explanations are not well-established.
- This review systematically assesses XAI methods in mammography and their evaluation.
Purpose of the Study:
- To systematically review XAI methods applied to mammography.
- To synthesize how explanations are evaluated for validity, robustness, and clinical usefulness.
- To identify gaps in current XAI research for mammography.
Main Methods:
- Systematic review following PRISMA 2020 guidelines.
- Searched major databases (MEDLINE, Embase, Scopus, Web of Science, Cochrane) from 2015-2026.
- Included studies using mammography with explicit explanation mechanisms; narrative synthesis and adapted XAI appraisal were used.
Main Results:
- Fourteen studies were included, focusing on detection, classification, or prediction.
- XAI methods included interpretable-by-design, saliency/attribution, and feature-level approaches.
- Most studies showed only qualitative plausibility; few had external validation or human-factor assessment; saliency benchmarks indicated modest lesion-pointing reliability.
Conclusions:
- Mammography XAI predominantly features visually plausible but inconsistently validated explanations.
- While intrinsically interpretable designs are emerging, external validation and clinician-centered evaluations are infrequent.
- Future research should prioritize pre-specified claims, quantitative metrics, robustness testing, and human decision-making studies.
